Despite calls from some leading health experts to scrap annual physicals because they are a waste of time and money, a new study finds advantages to routine screenings. “While it is disappointing that I can’t tell my...

TUESDAY, June 8, 2021 (American Heart Association News) — Running late after a hectic day, Jimmy Fremgen sprinted up a flight of stairs to his apartment. His hands shook so wildly he had trouble fitting the key...

TUESDAY, June 8, 2021 (American Heart Association News) — Black women are most likely to develop a severe form of high blood pressure during pregnancy called preeclampsia, a new study shows. But Asian and Pacific Islander women...

Jay-Fay Fraser was in the back seat of her father’s sedan, heading home from feeding the homeless on Thanksgiving 2016, when another car rear-ended them on the highway. The driver’s seat collapsed backward from the sudden force...

COVID-19 Vaccine Patent Rules Reconsidered by World Trade Organization A proposal to ease patents and related protections on COVID-19 vaccines in order to help developing nations fight the pandemic will be considered at a two-day meeting of...

Far too many women are showing up in U.S. emergency rooms due to fibroids, according to a new study spanning 12 years. Fibroids are common noncancerous growths in the uterus. They don’t always cause symptoms, but those...

(HealthDay News) – If you’re like most American adults, it might be time to reach for a piece of fruit, a plate of vegetables or a bowl of whole grains. Only 7% of adults get enough fiber,...

Advocates of plant-based diets suggest they can reduce the risk of chronic illnesses such as heart disease and help the environment. Now, new research suggests they may provide another health benefit: lowering COVID-19 severity. A plant-based diet...

New research suggests that many people who’ve undergone an organ transplant do not get an immune response from COVID-19 vaccines that’s strong enough to ward off a “breakthrough” infection. In a new review of 14 such cases,...

The U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer’s disease in nearly two decades, in a controversial decision that left the agency defending its reputation and its science. Aduhelm (aducanumab) treats...